VAXDYN
Vaxdyn develops vaccines using novel technology. They offers pathogen vaccines for preventing antibiotics-resistant infections. Their customers' inquiries are addressed through phone, email, and online applications.
VAXDYN
Industry:
Medical Pharmaceutical
Founded:
2011-01-01
Address:
Sevilla, Andalucia, Spain
Country:
Spain
Website Url:
http://www.vaxdyn.com
Total Employee:
11+
Status:
Active
Contact:
(34) 606660701
Email Addresses:
[email protected]
Total Funding:
892 K USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Apple Mobile Web Clips Icon Google Font API WordPress Content Delivery Network SSL By Default IPv6 ReCAPTCHA
Similar Organizations
Affinivax
Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Osciflex
Osciflex system imitates nature’s process to prevent deadly blood clots.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Pionyr Immunotherapeutics
Pionyr Immunotherapeutics is a developer of cancer immunotherapies designed to target the tumor microenvironment.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Trevarx Biomedical
Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.
Current Employees Featured
Founder
Investors List
CARB-X
CARB-X investment in Grant - Vaxdyn
Official Site Inspections
http://www.vaxdyn.com Semrush global rank: 13.98 M Semrush visits lastest month: 67
- Host name: chronos.hostns.io
- IP address: 91.204.209.217
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "Vaxdyn"
VAXDYN - LinkedIn
Headquartered in Seville, Spain, Vaxdyn works with an international network of collaborators in the development of multi-pathogen vaccines for preventing antibiotics-resistant infections in all...See details»
CARB-X is funding Spanish biotech Vaxdyn to develop a new …
Jul 7, 2020 · Vaxdyn is the first Spanish biotech to be funded by CARB-X, a non-profit partnership investing $500 million in the development of innovative vaccines, antibiotics and rapid …See details»
Vaxdyn - Carb-X
Www.vaxdyn.com. KAPAVAX TRIVALENT VACCINE TO PREVENT BACTERIAL PNEUMONIA Vaccine. By leveraging its proprietary vaccine platform based on LPS-null Acinetobacter …See details»
Vaxdyn Company Profile 2024: Valuation, Funding & Investors
When was Vaxdyn founded? Vaxdyn was founded in 2011. Where is Vaxdyn headquartered? Vaxdyn is headquartered in Dos Hermanas, Spain. What is the size of Vaxdyn? Vaxdyn has 9 …See details»
Vaxdyn | AseBio - Asociación Empresas BiotecnologÃa
Vaxdyn is a biotechnology company located in Seville, Spain that specializes in the discovery and development of antigens, immunomodulators, nanoparticles and mAbs for infectious diseases.See details»
CARB-X is funding Spanish biotech Vaxdyn to develop a new …
Vaxdyn’s new vaccine against Gram-negative pathogens, if approved, would help curb the rising threat of drug resistant bacteriaSee details»
Stewardship / Resistance Scan for Jul 07, 2020 - CIDRAP
Jul 7, 2020 · CARB-X announced today that it is awarding $892,000 to Spanish biotechnology company Vaxdyn to develop a vaccine to prevent infections caused by multidrug-resistant …See details»
Vaxdyn leads the KLEBSIELLA project to work on the …
Feb 28, 2024 · Vaxdyn leads the KLEBSIELLA research project against the antibiotic-resistant bacterium Klebsiella pneumoniae, which directly causes more than 650,000 deaths worldwide each year.See details»
Vaxdyn SL - Drug pipelines, Patents, Clinical trials - Synapse
Explore Vaxdyn SL with its drug pipeline, therapeutic area, technology platform, 1 news, Disease Domain:Infectious Diseases, Technology Platform:Vaccine, Prophylactic vaccine, Monoclonal …See details»
Vaxdyn consigue 14.5 millones del EIC Accelerator para financiar la ...
Gracias al apoyo de la aceleradora internacional CARB-X e inversores privados, Vaxdyn, con sede en Sevilla, ha logrado construir un paquete preclÃnico que ha validado su tecnologÃa …See details»
ASP Scan (Weekly) for Jul 10, 2020 - CIDRAP
Jul 10, 2020 · CARB-X announced today that it is awarding $892,000 to Spanish biotechnology company Vaxdyn to develop a vaccine to prevent infections caused by multidrug-resistant …See details»
VAXDYN - BIO International Convention 2024
VAXDYN. Biotech or pharma, therapeutic R&D Address Sevilla Sevilla Spain Contact Exhibitor. Full Name * Email Address * Contact Message * Please enter the code shown above * Submit …See details»
Vaxdyn: Una empresa española diseña una rompedora vacuna
Sep 19, 2021 · Junto a gigantes farmacéuticos como Sanofi, Janssen o Pfizer, la biotecnológica española Vaxdyn, en colaboración con una red de investigación y con el apoyo de la …See details»
Vaxdyn awarded €14.5 Million from the EIC Accelerator to Fund …
Sep 2, 2024 · Thanks to the support of the international accelerator CARB-X and private investors, Vaxdyn, based in Seville, has successfully built a preclinical package that has …See details»
Research programme: bacterial infection therapeutics - Vaxdyn
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases. Vaxdyn is developing vaccines for the prevention of bacterial infections. The …See details»
VAXDYN on LinkedIn: Vaxdyn wins one of the gold awards of the ...
The jury valued Vaxdyn’s proposal to tackle the silent pandemic of… Two weeks ago, in the Investor Day of #AcexHealth, Vaxdyn received a award from de jury.See details»
Using Omics Technologies and Systems Biology to Identify Epitope ...
Dec 9, 2019 · MM is a founding partner and shareholder in Vaxdyn, a biotechnology spin-off company developing vaccines and antibody-based therapies for antibiotic resistant infections …See details»
The Fight Against Pneumonia and Antibiotic Resistance: Vaxdyn …
On the occasion of World Pneumonia Day, we interviewed Juanjo Infante, CEO of Vaxdyn, a biotech company developing the K-Vax vaccine candidate against Klebsiella pneumoniae, …See details»
The R&D landscape for infectious disease vaccines - Nature
Jul 20, 2023 · Vaccines have a tremendous impact on public health, and their importance has been emphasized by the COVID-19 pandemic. Here, we provide an overview of the current …See details»
Vaxdyn and the University of Latvia have obtained funding from …
Apr 22, 2024 · They receive a grant of half a million euros to prepare the clinical and commercial strategy for vaccination against Klebsiella pneumoniae and Acinetobacter baumannii bacteria.See details»